http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2427301-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd8803dc2eb669225d15d0d2f661de7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662 |
| filingDate | 2001-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_976f3d4554abb8430f484be2333c3593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bacc2904d14524712f1b98681e05d53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84854ec58d2fb20bbe37c90865be77e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059995325266b6329a49964297b5703e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef7be68e548863c51022db2536c2d40b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92503925eaa89f9912c7c7a78ffa75d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7a2272e4e4c9c2732d87b1b3e63609c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58fb65df5c03d32f3a198ef179d666a2 |
| publicationDate | 2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2427301-A1 |
| titleOfInvention | Method for the preparation of a pharmaceutical composition, and its use |
| abstract | The present invention is directed to a method for the preparation of a pharmaceutical composition having osteoclast formation inhibiting or suppressing activity, characterized in that, as the active agent, a compound of the formula (I) is used, in which formula Q1 is hydrogen, hydroxyl, halogen, amino -NH2, or -OR', wherein R' is C1-C4-alkyl or acyl, Q2 is straight or branched alkyl, hydroxyalkyl or aminoalkyl, or a corresponding unsaturated group optionally substituted at the hydroxy or amino group, or a unsubstituted or substituted, saturated or unsaturated cycloalkyl, which can be bound to the methylene carbon over a straight or branched alkylene group, or is the group (a) wherein Y is a saturated or unsaturated heterocyclic group, or a carbocyclic aromatic group, X is a bond, O, S or NR3, wherein R3 is hydrogen or a protecting group, especially lower alkyl, acyl, aryl or arylalkyl, and n is an integer 0 to 6, R1 and R2 are independently hydrogen or C1-C4-alkyl, or it is halogen, and the groups R1 to R4 are the same or different, and mean an alkyl group with 1 - 5 carbon atoms, whereby one or two of the groups R1 to R4 can also mean hydrogen, or a pharmacologically acceptable salt thereof. |
| priorityDate | 2000-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.